110 related articles for article (PubMed ID: 3489555)
1. Peripheral T-cell subsets in asymptomatic hepatitis B-virus carriers.
Chu CM; Liaw YF
Cell Immunol; 1986 Apr; 98(2):533-7. PubMed ID: 3489555
[TBL] [Abstract][Full Text] [Related]
2. Peripheral T-cell subsets in chronic type B hepatitis: correlation with biochemical and histological activities and hepatitis B e antigen/antibody status.
Chu CM; Liaw YF; Yang CY; Sheen IS
Cell Immunol; 1984 Jul; 86(2):562-6. PubMed ID: 6234072
[TBL] [Abstract][Full Text] [Related]
3. Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan: a comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
Liaw YF; Chu CM; Lin DY; Sheen IS; Yang CY; Huang MJ
J Med Virol; 1984; 13(4):385-91. PubMed ID: 6330293
[TBL] [Abstract][Full Text] [Related]
4. Peripheral T-cell phenotypes in chronic active hepatitis B. Correlation with serum hepatitis B virus (HBV) markers and clinical features.
Carneiro de Moura M; Lucas M; Victorino RM
J Hepatol; 1986; 3 Suppl 2():S301-4. PubMed ID: 3496377
[TBL] [Abstract][Full Text] [Related]
5. Relationship between T cell subsets and suppressor cell activity in chronic hepatitis B virus (HBV) infection.
Barnaba V; Musca A; Cordova C; Levrero M; Ruocco G; Albertini-Petroni V; Balsano F
Clin Exp Immunol; 1983 Aug; 53(2):281-8. PubMed ID: 6224609
[TBL] [Abstract][Full Text] [Related]
6. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y
Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
[TBL] [Abstract][Full Text] [Related]
7. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
[TBL] [Abstract][Full Text] [Related]
8. T-cell subsets in the hyporesponsiveness to hepatitis B surface antigen (HBsAg) and antigen-specific suppressor lymphocytes in chronic hepatitis B virus (HBV) infection.
Barnaba V; Levrero M; Van Dyke AD; Musca A; Cordova C; Balsano F
Clin Immunol Immunopathol; 1985 Mar; 34(3):284-95. PubMed ID: 2578908
[TBL] [Abstract][Full Text] [Related]
9. HBV-DNA, HBeAg/anti-HBe serological status in hepatitis B chronic individuals from central Italy.
Rapicetta M; di Nardo V; Rozera C; Marinucci G; Francisci D; Sarrecchia B; Ricci C; Albertoni F
Epidemiol Infect; 1990 Jun; 104(3):511-7. PubMed ID: 2347388
[TBL] [Abstract][Full Text] [Related]
10. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.
Bonino F; Rosina F; Rizzetto M; Rizzi R; Chiaberge E; Tardanico R; Callea F; Verme G
Gastroenterology; 1986 May; 90(5 Pt 1):1268-73. PubMed ID: 3956945
[TBL] [Abstract][Full Text] [Related]
11. T cell subsets in autoimmune and HBV-induced chronic liver disease, HBs antigen carriers with normal histology and primary biliary cirrhosis: a review of the abnormalities and the effects of treatment.
Thomas HC; Brown D; Labrooy J; Epstein O
J Clin Immunol; 1982 Jul; 2(3 Suppl):57S-60S. PubMed ID: 6752180
[TBL] [Abstract][Full Text] [Related]
12. Immunoregulatory T cells in HBV-induced chronic liver disease as defined by monoclonal antibodies.
Barnaba V; Zaccari C; Levrero M; Ruocco G; Balsano F
Clin Immunol Immunopathol; 1983 Jan; 26(1):83-90. PubMed ID: 6223742
[TBL] [Abstract][Full Text] [Related]
13. [Hepatitis B virus DNA as a marker of viral multiplication: comparison with HBe antigen and anti-HBe antibody].
Thiers V; Bouchardeau F; Courouce AM; Tiollais P; Brechot C
Presse Med; 1986 Jun; 15(26):1219-22. PubMed ID: 2944091
[TBL] [Abstract][Full Text] [Related]
14. T-lymphocyte subpopulations in patients with various courses after hepatitis B virus infection.
van Hattum J; van Oudenaren A; Schalm SW; Visser JW; Benner R
Scand J Gastroenterol; 1984 Jun; 19(4):497-501. PubMed ID: 6611578
[TBL] [Abstract][Full Text] [Related]
15. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection.
Ferrari C; Penna A; Bertoletti A; Valli A; Antoni AD; Giuberti T; Cavalli A; Petit MA; Fiaccadori F
J Immunol; 1990 Nov; 145(10):3442-9. PubMed ID: 2230128
[TBL] [Abstract][Full Text] [Related]
16. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus DNA polymerase activity and hepatitis B e antigen (HBeAg)/anti-HBe status among type B chronic liver diseases.
Kashiwagi S; Hayashi J; Ikematsu H; Nomura H; Kajiyama W; Shingu T; Hayashida K; Kaji M
Gastroenterol Jpn; 1988 Apr; 23(2):117-23. PubMed ID: 3384275
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology.
Stroffolini T; Sagnelli E; Rapicetta M; Felaco FM; Filippini P; Annella T; Petruzziello A; Chionne P; Sarrecchia B; Piccinino F
Hepatogastroenterology; 1992 Feb; 39(1):62-5. PubMed ID: 1568710
[TBL] [Abstract][Full Text] [Related]
19. Infectivity in asymptomatic hepatitis B carriers: its correlation with HBeAg/anti-HBe status.
Cheng NY; Chang JG; Liao ST; Liu JD; Lee LS; Chen PH; Choo KB
Taiwan Yi Xue Hui Za Zhi; 1989 Feb; 88(2):148-51. PubMed ID: 2769214
[TBL] [Abstract][Full Text] [Related]
20. Possible mechanisms underlying peripheral lymphocyte activation in chronic liver disease and asymptomatic HBsAg carriers.
Raptopoulou-Gigi M; Orphanou-Koumerkeridou H; Lagra F
Allergol Immunopathol (Madr); 1989; 17(3):145-8. PubMed ID: 2683681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
